• Exein

  Participated · Series C · Jul 2025

  Exein develops an embedded, hardware-agnostic cybersecurity platform that integrates runtime security directly into device firmware, allowing connected devices to detect, contain and respond to threats even when offline. The system already safeguards more than 1.5 billion devices in sectors such as energy, healthcare, defence, automotive, aerospace and industrial automation, and the company projects this figure will surpass two billion in Q1 2026. Exein’s technology supports integrity checks across supply chains and helps manufacturers comply with regulations like RED 3.3, the forthcoming EU Cyber Resilience Act and the US Cyber Trust Mark. Looking ahead, the firm plans to release next-generation protections for on-device AI and large language models, with an initial unveiling slated for RSAC 2026. The new capital will also fund a multi-transaction M&A programme in 2026 and accelerate expansion in the US and APAC. Exein has experienced a significant valuation uplift since mid-2025, reflecting rising demand for device-level security and its strengthened commercial position.

• Cambridge Mechatronics

  Participated · Equity · Feb 2024

  Cambridge Mechatronics (CML) designs and controls Shape Memory Alloy (SMA) actuators and dedicated controller ICs primarily for smartphone imaging. Its SMA products, including an SMA Variable Aperture and patented Zero Hold Power technology, provide compact, lightweight autofocus and optical image stabilization while avoiding electromagnetic interference associated with voice coil motors. CML has shipped its technology in over 70 million products to date and holds over 700 patents pending and granted. The company intends to expand its SMA actuator and semiconductor platform beyond smartphone cameras into healthcare, precision drug delivery, haptics for smartphones and game controllers, and interactive entertainment. The recent oversubscribed funding will support growth of its actuator and controller IC product portfolios and accelerate team expansion and commercialization.

• DoinGud

  Participated · Seed · Sep 2021

  DoinGud is a blockchain-based creator ecosystem that enables creators to upload and sell NFTs while directing a portion of primary and secondary sales to pre-vetted social impact organizations aligned with the UN Sustainable Development Goals. The platform is designed to be accessible to users with no prior crypto or blockchain experience and supports allocation of 5%–95% of primary sales and 2.5% of secondary sales to charities. Founded in early 2021 and based in Zug, Switzerland, DoinGud plans to launch in November 2021 and already has a roster of established creators committed to the platform. The project emphasizes community ownership and curation, aiming to create sustainable income streams and lasting impact for causes creators care about. Financially, DoinGud secured a $5 million seed raise to develop new features and tools to make NFTs more accessible and to expand charitable-giving functionality.

• Simple

  Participated · Series A · Dec 2020

  Founded in 2019 by Mike Prytkov, Simple delivers weight-loss coaching through its AI assistant, Avo, which tailors nutrition, fasting, movement, and habit recommendations to each user. The app eschews generic calorie tracking in favor of real-time, individualized feedback, handling more than 100,000 daily coaching conversations and processing nearly 300,000 meal logs. Simple reports 700,000 subscribers and an annual recurring revenue run-rate of $160 million, and Prytkov says the business is already profitable. Its competitive set includes Noom, WeightWatchers, and MyFitnessPal, yet Simple differentiates itself with closed-loop LLM-driven personalization and by serving as a behavioral companion for GLP-1 medication users. Future product plans include deeper GLP-1 integrations, women’s health and midlife programs, and broader wellness modules covering sleep, stress, and movement. Prytkov’s long-term vision is for Simple to become the "Duolingo of health," a daily, engaging companion for building healthy habits.

• aveni

  Participated · Equity · Oct 2017

  aveni develops and supplies wet deposition technologies and Electrografting™ chemistries and processes aimed at 2D interconnects and 3D TSV packaging for the semiconductor and electronics industry. The company is led by CEO Bruno Morel and is based in Massy, France. It completed a €8.9M ($10.5M) Series B financing. Backers named in the round include Merck Ventures and existing investors such as Samsung Venture Investment Corporation, Panasonic, ALIAD (Air Liquide Venture Capital), Auriga Partners, Supernova and Idinvest Partners. aveni intends to use the funds to commercialize its technologies. No operating metrics were disclosed in the article. aveni (fka Alchimer S.A.) develops wet electrochemical metallization processes—Electrografting (eG™) for conductive substrates and Chemicalgrafting (cG™) for nonconductive substrates—targeted at damascene, TSVs, MEMS and other electronic applications. The company’s technology enables growth of high‑quality thin films and is currently in the qualification phase for the dual‑damascene process at the 10nm node with three leading logic manufacturers. aveni secured $13.5M in funding to support commercial expansion and technology adoption. It announced formation of a U.S. subsidiary based in Silicon Valley to support the U.S. market. Led by CEO Bruno Morel, the company plans to use the proceeds to grow and expand adoption of its metallization products.

No current team members are available.